I am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter @theroberthart or email me at [email protected]
Indonesia has become the first country in the world to greenlight Novavax’s Covid-19 vaccine, the Maryland-based biotechMonday, a possible game changer in the fight against the pandemic and a major milestone for the company, which has been plagued with manufacturing difficulties and has not managed to bring a vaccine to market in its 34-year history. Key Facts
Indonesia’s medicines regulator granted emergency use authorization to Novavax’s Covid-19 vaccine Monday, which will be produced by the Serum Institute of India, the world’s largest vaccine manufacturer by volume. The green light marks the first time a regulator has approved a protein-based vaccine for Covid-19 based on, Novavax said, and the first time a regulator has approved any vaccine produced by Novavax.
Novavax said a phase 3 trial of the shot, which is given in two doses 21-days apart, found it was 100% effective against moderate and severe disease and was 90% effective at preventing Covid-19.While late to arrive, the Novavax shot has a number of advantages over existing vaccines and could help ramp up vaccination worldwide.
issues, especially in light of its more than 1 billion doses promised to low- and middle-income countries and the widening chasm in vaccine access between wealthy nations and the rest of the world.Stanley Erck, Novavax’s chief executive, said the “landmark moment… is the first of many authorizations that Novavax expects in the coming weeks and months for our vaccine.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Novavax COVID-19 vaccine receives first emergency use authorizationNovavax Inc and partner Serum Institute of India said on Monday they received emergency use authorization for their COVID-19 vaccine in Indonesia, making it the first approval anywhere in the world for Novavax.
Baca lebih lajut »
U.S. to Exempt Certain Foreign Air Travelers From Covid-19 Vaccine RulesChildren and those from countries with low supplies of Covid-19 vaccines will be exempt from new requirements that foreign nationals show proof of vaccination to fly to the U.S., the Biden administration said.
Baca lebih lajut »
Is the COVID-19 vaccine safe for children?Is the COVID-19 vaccine safe for kids? Yes. The FDA authorized Pfizer's vaccine for 5- to 11-year-olds after assessing the safety of doses given to 3,100 youngsters. Those doses are a third the size of those given safely to millions of teens and adults.
Baca lebih lajut »
FDA Authorizes Use Of Pfizer's COVID-19 Vaccine For Kids 5-11The Food and Drug Administration (FDA) has just authorized Pfizer's COVID-19 vaccine for children ages 5-11.
Baca lebih lajut »
The Science You Need To Make Your COVID-19 DecisionsAn updating tracker of the latest science on Covid, including how likely you are to catch and spread coronavirus if you’re vaccinated, the best face masks for COVID-19, what Covid test you should take, the rate of long COVID, and how likely kids are to get sick.
Baca lebih lajut »